|
Roar's fluorescence-based, patented
products include kits to measure the activity of cholesteryl
ester transfer protein (CETP), microsomal [triglyceride] transfer
protein (MTP), lecithin:cholesterol acyltransferase (LCAT)
and lipoprotein lipase (LPL).
In the drug discovery sector, the products
are outfitted with Roar's proprietary screening platform,
Spectral Interference Protection (SIP). Spectral interference
(color quenching) limits the use of fluorescence spectroscopy
in drug discovery. SIP offers the pharmaceutical industry
a new technique in
high-throughput screening that eliminates the use of radioactivity.
Roar supports clinical studies at several
research institutions. Future plans include a line of photometric
assays utilizing a patent pending technique that increases
sensitivity over conventional methods.
Our office and laboratory is located
in New York City at Columbia University's Audubon Biomedical
Center. Please take a look around our website for more information
on our products and other items of interest.
|